SOUTH PLAINFIELD, N.J., Sept. 2 /PRNewswire/ -- PTC Therapeutics, Inc. (PTC)
today announced that Celgene Corporation has exercised its option to
collaborate on advancing drug discovery efforts on an oncology target
addressed through the application of PTC's GEMS(TM) (Gene Expression
Modulation by Small-molecules) technology.
